Large orders to go out to sea heat up the pharmaceutical sector, China's first "drug ETF" is about to be launched.

According to the fund announcement, on May 26, the first domestic "Pharmaceutical ETF" will be launched. Industry insiders pointed out that Sansei Pharmaceutical's PD-1 dual antibody entering the international market has set a new record, inspiring the entire pharmaceutical industry. In the future, as more Chinese pharmaceutical companies participate in international competition, more Chinese good medicines will have commercialization opportunities, shine in the global pharmaceutical market, and also promote China's transition from a pharmaceutical power to a pharmaceutical powerhouse.